Literature DB >> 16480843

[Efficacy and tolerance of antiretroviral therapy in HIV-2 infected patients in Dakar: preliminary study].

C T Ndour1, G Batista, N M Manga, N F Ngom Guèye, N M Dia Badiane, L Fortez, P S Sow.   

Abstract

OBJECTIVE: The authors had for aim to evaluate the clinical and immunological response as well as the tolerance to antiretroviral therapy in HIV-2 infected patients.
DESIGN: A retrospective chart review was made from August 1998 to August 2004.
RESULTS: 188 patients were on protease inhibitor based regimen. 153 (81.38%) were HIV-1 and 35 (18.62%) HIV-2 infected patients. The mean weight gain was significantly higher in the HIV-2 group at months 9 and 12 (P=0.02 et P=0.01 respectively), whereas CD4 cells count gain was higher in the HIV-1 group at month 6 (P=0.004). New AIDS defining criteria are less likely to occur in HIV-2 infected patients on HAART than in HIV-1 (P=0.004). Lipodystrophy syndrome was present only in HIV-1 infected patients.
CONCLUSION: Antiretroviral therapy in HIV-2 infected patients shows similar clinical and immunological efficacy than in HIV-1 infected ones and is also well tolerated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16480843     DOI: 10.1016/j.medmal.2005.11.012

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  6 in total

1.  Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa.

Authors:  Geoffrey S Gottlieb; Ndeye Mery Dia Badiane; Stephen E Hawes; Louise Fortes; Macoumba Toure; Cheikh T Ndour; Alison K Starling; Fatou Traore; Fatima Sall; Kim G Wong; Stephen L Cherne; Donovan J Anderson; Stefanie A Dye; Robert A Smith; James I Mullins; Nancy B Kiviat; Papa Salif Sow
Journal:  Clin Infect Dis       Date:  2009-02-15       Impact factor: 9.079

2.  Comparing Treatment Outcomes of Antiretroviral Therapy in HIV-1 and HIV-2 Infected Patients, in Bamako, Mali.

Authors:  Aboubacar Alassane Oumar; Yacouba Cissoko; Issa Konaté; Adam Kane; Jean Paul Dembélé; Mamadou Cissé; Robert Leo Murphy; Jean Cyr Yombi; Moussa Seydi; Sounkalo Dao; Mamoudou Maiga
Journal:  Curr Find Infect Dis       Date:  2018-11-26

Review 3.  Antiretroviral therapy response among HIV-2 infected patients: a systematic review.

Authors:  Didier K Ekouevi; Boris K Tchounga; Patrick A Coffie; Joseph Tegbe; Alexandra M Anderson; Geoffrey S Gottlieb; Marco Vitoria; François Dabis; Serge P Eholie
Journal:  BMC Infect Dis       Date:  2014-08-26       Impact factor: 3.090

4.  [HIV-2 infection in Senegal: virological failures and resistance to antiretroviral drugs (ARVs)].

Authors:  Selly Ba; Ndeye Mery Dia-Badiane; Stephen Edward Hawes; Louise Fortes Deguenonvo; Fatima Sall; Cheikh Tidiane Ndour; Khadim Faye; Fatou Traoré; Macoumba Touré; Marie Pierre Sy; Dana Noelle Raugi; Nancy Berenice Kiviat; Robert Alexander Smith; Moussa Seydi; Papa Salif Sow; Geoffrey Scott Gottlieb
Journal:  Pan Afr Med J       Date:  2019-07-18

5.  A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa.

Authors:  Geoffrey S Gottlieb; Serge-Paul Eholié; John N Nkengasong; Sabelle Jallow; Sarah Rowland-Jones; Hilton C Whittle; Papa Salif Sow
Journal:  AIDS       Date:  2008-10-18       Impact factor: 4.177

6.  Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

Authors:  Jean Ruelle; François Roman; Anne-Thérèse Vandenbroucke; Christine Lambert; Katrien Fransen; Fedoua Echahidi; Denis Piérard; Chris Verhofstede; Kristel Van Laethem; Marie-Luce Delforge; Dolorès Vaira; Jean-Claude Schmit; Patrick Goubau
Journal:  BMC Infect Dis       Date:  2008-02-27       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.